Literature DB >> 15569627

Functional protein-protein interaction of drug metabolizing enzymes.

Yuji Ishii1, Shuso Takeda, Hideyuki Yamada, Kazuta Oguri.   

Abstract

Cytochrome P450 (P450, CYP), a major class of enzymes involved in Phase I drug metabolism, is expressed in the cellular endoplasmic reticulum together with other enzymes, such as microsomal epoxide hydrolase (mEH) and UDP-glucuronosyltransferase (UGT). In many cases, the metabolite produced by P450 is sequentially metabolized by other enzymes to increase its water solubility. It would be reasonable to assume that the metabolite produced by P450 is directly transferred to the other enzymes participating in its subsequent metabolism via protein-protein interactions for rapid metabolism. However, these steps have been considered to take place individually. Previously, we suggested that CYP1A1 specifically associates with mEH, UGTs and NADPH-P450 reductase. This observation strongly supports the view that there is functional cooperation between P450 and mEH/UGT to facilitate multistep drug metabolism. In recent years, accumulating evidence suggests the interaction between drug metabolizing enzymes and a change in enzymatic function by this interaction. In this review, we summarize the interaction between drug metabolizing enzymes and discuss its impact on their function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15569627     DOI: 10.2741/1583

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

1.  Development of monoclonal antibodies to human microsomal epoxide hydrolase and analysis of "preneoplastic antigen"-like molecules.

Authors:  Hongying Duan; Kazunori Yoshimura; Nobuharu Kobayashi; Kazuo Sugiyama; Jun-Ichi Sawada; Yoshiro Saito; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  Identification of cytochrome P450 2C2 protein complexes in mouse liver.

Authors:  Bin Li; Peter Yau; Byron Kemper
Journal:  Proteomics       Date:  2011-08       Impact factor: 3.984

3.  Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

4.  Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.

Authors:  C Preston Pugh; Dakota L Pouncey; Jessica H Hartman; Robert Nshimiyimana; Linda P Desrochers; Thomas E Goodwin; Gunnar Boysen; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2014-10-19       Impact factor: 4.013

5.  Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A.

Authors:  Toshitaka Akatsuka; Nobuharu Kobayashi; Takashi Ishikawa; Takafumi Saito; Michiko Shindo; Masayoshi Yamauchi; Kazutaka Kurokohchi; Hitoshi Miyazawa; Hongying Duan; Toshiyuki Matsunaga; Tsugikazu Komoda; Christophe Morisseau; Bruce D Hammock
Journal:  J Autoimmun       Date:  2007-02-12       Impact factor: 7.094

6.  Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

Authors:  Yingjie Wei; Baojian Wu; Wen Jiang; Taijun Yin; Xiaobin Jia; Sumit Basu; Guangyi Yang; Ming Hu
Journal:  Mol Pharm       Date:  2013-04-23       Impact factor: 4.939

7.  Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes.

Authors:  Camille M Konopnicki; Leslie J Dickmann; Jeffrey M Tracy; Robert H Tukey; Larry C Wienkers; Robert S Foti
Journal:  Arch Biochem Biophys       Date:  2013-04-04       Impact factor: 4.013

8.  Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.

Authors:  Meifang Wang; Guangyi Yang; Yu He; Beibei Xu; Min Zeng; Shufan Ge; Taijun Yin; Song Gao; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-07-06       Impact factor: 5.914

9.  The evolution of ultraconserved elements with different phylogenetic origins.

Authors:  Taewoo Ryu; Loqmane Seridi; Timothy Ravasi
Journal:  BMC Evol Biol       Date:  2012-12-05       Impact factor: 3.260

10.  Ethylene oxide in blood of ethylene-exposed B6C3F1 mice, Fischer 344 rats, and humans.

Authors:  Johannes Georg Filser; Winfried Kessler; Anna Artati; Eva Erbach; Thomas Faller; Paul Erich Kreuzer; Qiang Li; Josef Lichtmannegger; Wanwiwa Numtip; Dominik Klein; Christian Pütz; Brigitte Semder; György András Csanády
Journal:  Toxicol Sci       Date:  2013-09-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.